| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Norovirus | 82 | 2025 | 317 | 18.250 |
Why?
|
| Rotavirus | 146 | 2024 | 497 | 16.190 |
Why?
|
| Caliciviridae Infections | 91 | 2025 | 328 | 14.140 |
Why?
|
| Rotavirus Infections | 79 | 2024 | 354 | 10.860 |
Why?
|
| Gastroenteritis | 69 | 2025 | 348 | 9.760 |
Why?
|
| Virus Replication | 54 | 2025 | 607 | 9.470 |
Why?
|
| Norwalk virus | 68 | 2024 | 170 | 9.160 |
Why?
|
| Viral Nonstructural Proteins | 57 | 2020 | 190 | 8.710 |
Why?
|
| Organoids | 33 | 2025 | 280 | 8.350 |
Why?
|
| Glycoproteins | 34 | 2024 | 367 | 4.900 |
Why?
|
| Capsid Proteins | 53 | 2023 | 184 | 4.770 |
Why?
|
| Antibodies, Viral | 56 | 2024 | 1150 | 4.760 |
Why?
|
| Viral Vaccines | 34 | 2025 | 337 | 4.740 |
Why?
|
| Toxins, Biological | 31 | 2019 | 69 | 4.630 |
Why?
|
| Intestines | 30 | 2025 | 577 | 4.310 |
Why?
|
| Intestinal Mucosa | 36 | 2025 | 781 | 4.290 |
Why?
|
| Host-Pathogen Interactions | 16 | 2025 | 253 | 4.180 |
Why?
|
| Capsid | 57 | 2023 | 142 | 4.010 |
Why?
|
| Blood Group Antigens | 18 | 2025 | 73 | 3.950 |
Why?
|
| Virion | 32 | 2020 | 147 | 3.230 |
Why?
|
| Antigens, Viral | 47 | 2020 | 438 | 3.100 |
Why?
|
| RNA, Viral | 45 | 2024 | 537 | 2.900 |
Why?
|
| Stem Cells | 17 | 2023 | 710 | 2.610 |
Why?
|
| Calcium | 18 | 2020 | 1105 | 2.230 |
Why?
|
| Intestine, Small | 14 | 2024 | 310 | 2.190 |
Why?
|
| Gastrointestinal Diseases | 7 | 2021 | 339 | 2.180 |
Why?
|
| Bile Acids and Salts | 5 | 2024 | 244 | 2.100 |
Why?
|
| Rotavirus Vaccines | 12 | 2018 | 72 | 2.060 |
Why?
|
| Antibodies, Neutralizing | 4 | 2024 | 469 | 1.990 |
Why?
|
| Cell Culture Techniques | 8 | 2021 | 275 | 1.870 |
Why?
|
| Epithelial Cells | 14 | 2022 | 909 | 1.840 |
Why?
|
| Cell Line | 55 | 2021 | 2756 | 1.830 |
Why?
|
| Genotype | 25 | 2024 | 2569 | 1.790 |
Why?
|
| RNA-Binding Proteins | 11 | 2020 | 578 | 1.760 |
Why?
|
| Humans | 275 | 2025 | 125110 | 1.730 |
Why?
|
| Caliciviridae | 13 | 2019 | 19 | 1.710 |
Why?
|
| Viral Proteins | 17 | 2021 | 347 | 1.710 |
Why?
|
| Viruses | 7 | 2022 | 122 | 1.680 |
Why?
|
| Polysaccharides | 11 | 2022 | 138 | 1.670 |
Why?
|
| Animals | 163 | 2024 | 34304 | 1.650 |
Why?
|
| Virus Internalization | 3 | 2023 | 55 | 1.630 |
Why?
|
| Receptors, Virus | 16 | 2020 | 108 | 1.620 |
Why?
|
| Virus Assembly | 13 | 2019 | 47 | 1.610 |
Why?
|
| Virus Cultivation | 5 | 2024 | 76 | 1.570 |
Why?
|
| Antibodies, Monoclonal | 23 | 2021 | 1026 | 1.560 |
Why?
|
| Endoplasmic Reticulum | 12 | 2019 | 217 | 1.460 |
Why?
|
| Genome, Viral | 20 | 2024 | 165 | 1.420 |
Why?
|
| Models, Biological | 16 | 2021 | 1465 | 1.400 |
Why?
|
| Feces | 47 | 2021 | 727 | 1.340 |
Why?
|
| Antiviral Agents | 10 | 2025 | 767 | 1.320 |
Why?
|
| Cytoplasm | 6 | 2020 | 296 | 1.310 |
Why?
|
| Interferons | 4 | 2020 | 126 | 1.310 |
Why?
|
| Peptide Hydrolases | 7 | 2021 | 145 | 1.250 |
Why?
|
| Virus Physiological Phenomena | 3 | 2018 | 14 | 1.250 |
Why?
|
| Antibodies, Blocking | 5 | 2024 | 62 | 1.230 |
Why?
|
| Communicable Diseases | 3 | 2022 | 160 | 1.230 |
Why?
|
| Diarrhea | 25 | 2023 | 315 | 1.200 |
Why?
|
| Amino Acid Sequence | 47 | 2021 | 2717 | 1.150 |
Why?
|
| Molecular Sequence Data | 55 | 2014 | 3898 | 1.120 |
Why?
|
| Epitope Mapping | 6 | 2021 | 80 | 1.090 |
Why?
|
| Epitopes | 15 | 2023 | 433 | 1.090 |
Why?
|
| Plasmids | 3 | 2020 | 513 | 1.070 |
Why?
|
| Cell Membrane | 5 | 2023 | 464 | 1.040 |
Why?
|
| Tissue Engineering | 5 | 2020 | 174 | 0.990 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 30 | 2016 | 825 | 0.970 |
Why?
|
| Organ Culture Techniques | 5 | 2021 | 154 | 0.960 |
Why?
|
| Biliary Atresia | 3 | 2013 | 190 | 0.940 |
Why?
|
| Vaccination | 9 | 2020 | 961 | 0.940 |
Why?
|
| Virus Diseases | 4 | 2021 | 281 | 0.940 |
Why?
|
| Vaccines, Virus-Like Particle | 5 | 2024 | 33 | 0.930 |
Why?
|
| Gastrointestinal Microbiome | 5 | 2024 | 698 | 0.920 |
Why?
|
| Secretory Pathway | 3 | 2019 | 12 | 0.910 |
Why?
|
| Virus Attachment | 10 | 2021 | 41 | 0.910 |
Why?
|
| Intestinal Diseases | 4 | 2019 | 83 | 0.890 |
Why?
|
| Cell Differentiation | 9 | 2024 | 1910 | 0.850 |
Why?
|
| Bile | 2 | 2021 | 46 | 0.850 |
Why?
|
| Virulence Factors | 5 | 2021 | 172 | 0.830 |
Why?
|
| Genes, Viral | 17 | 2000 | 185 | 0.830 |
Why?
|
| Cells, Cultured | 20 | 2021 | 3044 | 0.820 |
Why?
|
| Mice | 59 | 2024 | 17740 | 0.820 |
Why?
|
| Protease Inhibitors | 4 | 2025 | 96 | 0.800 |
Why?
|
| Escherichia coli | 12 | 2021 | 968 | 0.800 |
Why?
|
| CRISPR-Cas Systems | 2 | 2022 | 256 | 0.780 |
Why?
|
| Disinfectants | 1 | 2022 | 25 | 0.760 |
Why?
|
| Immunoglobulin A | 18 | 2016 | 207 | 0.760 |
Why?
|
| Gastrointestinal Tract | 2 | 2021 | 212 | 0.750 |
Why?
|
| Milk, Human | 5 | 2025 | 300 | 0.750 |
Why?
|
| Virology | 5 | 2013 | 31 | 0.750 |
Why?
|
| Lentivirus | 1 | 2022 | 82 | 0.750 |
Why?
|
| Adult Stem Cells | 2 | 2019 | 54 | 0.740 |
Why?
|
| Oligosaccharides | 2 | 2018 | 75 | 0.720 |
Why?
|
| Neutralization Tests | 13 | 2024 | 236 | 0.710 |
Why?
|
| Reverse Genetics | 1 | 2020 | 15 | 0.700 |
Why?
|
| Open Reading Frames | 10 | 2014 | 212 | 0.700 |
Why?
|
| Jejunum | 6 | 2024 | 127 | 0.700 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2019 | 247 | 0.680 |
Why?
|
| Hepatitis B virus | 1 | 2021 | 130 | 0.680 |
Why?
|
| Enterocytes | 6 | 2024 | 74 | 0.680 |
Why?
|
| COP-Coated Vesicles | 1 | 2019 | 4 | 0.660 |
Why?
|
| Lipid Droplets | 1 | 2020 | 47 | 0.660 |
Why?
|
| Culture Media | 5 | 2024 | 181 | 0.660 |
Why?
|
| Baculoviridae | 19 | 2003 | 64 | 0.660 |
Why?
|
| Ceramides | 1 | 2020 | 38 | 0.650 |
Why?
|
| Models, Molecular | 20 | 2021 | 1084 | 0.650 |
Why?
|
| Protein Transport | 8 | 2019 | 369 | 0.650 |
Why?
|
| Gene Expression Regulation, Viral | 6 | 2013 | 131 | 0.640 |
Why?
|
| Protein Structure, Tertiary | 16 | 2014 | 768 | 0.640 |
Why?
|
| Escherichia coli Infections | 5 | 2021 | 182 | 0.620 |
Why?
|
| ABO Blood-Group System | 7 | 2012 | 66 | 0.620 |
Why?
|
| Interleukins | 2 | 2016 | 120 | 0.600 |
Why?
|
| Genes, Reporter | 3 | 2014 | 381 | 0.590 |
Why?
|
| Interferon Type I | 2 | 2016 | 108 | 0.590 |
Why?
|
| Inclusion Bodies | 2 | 2018 | 48 | 0.580 |
Why?
|
| Phosphorylation | 7 | 2020 | 1640 | 0.580 |
Why?
|
| Immunity, Mucosal | 10 | 2019 | 87 | 0.580 |
Why?
|
| Crystallography, X-Ray | 16 | 2022 | 358 | 0.580 |
Why?
|
| Microchip Analytical Procedures | 1 | 2017 | 6 | 0.560 |
Why?
|
| Immunization | 8 | 2006 | 308 | 0.560 |
Why?
|
| Regeneration | 1 | 2019 | 210 | 0.550 |
Why?
|
| Cross Reactions | 8 | 2021 | 192 | 0.550 |
Why?
|
| Microfluidics | 1 | 2017 | 22 | 0.550 |
Why?
|
| Rabbits | 22 | 2023 | 718 | 0.540 |
Why?
|
| Species Specificity | 14 | 2017 | 551 | 0.540 |
Why?
|
| Autophagy | 3 | 2019 | 395 | 0.530 |
Why?
|
| DNA Replication | 1 | 2018 | 357 | 0.530 |
Why?
|
| Antibody Formation | 6 | 2012 | 265 | 0.530 |
Why?
|
| Recombinant Fusion Proteins | 8 | 2014 | 771 | 0.520 |
Why?
|
| Immune Evasion | 1 | 2016 | 35 | 0.520 |
Why?
|
| Polymerase Chain Reaction | 13 | 2016 | 1592 | 0.510 |
Why?
|
| Protein Binding | 14 | 2021 | 1756 | 0.510 |
Why?
|
| Shellfish | 9 | 2022 | 31 | 0.510 |
Why?
|
| Immunoglobulin G | 16 | 2016 | 780 | 0.510 |
Why?
|
| Signal Transduction | 8 | 2023 | 4597 | 0.500 |
Why?
|
| Adult | 34 | 2025 | 29459 | 0.490 |
Why?
|
| Protein Conformation | 14 | 2021 | 837 | 0.490 |
Why?
|
| Women, Working | 1 | 2015 | 9 | 0.490 |
Why?
|
| Mice, Inbred BALB C | 13 | 2017 | 1000 | 0.480 |
Why?
|
| Immunity, Innate | 7 | 2024 | 372 | 0.480 |
Why?
|
| Protein Multimerization | 2 | 2018 | 128 | 0.480 |
Why?
|
| Enterotoxins | 6 | 2008 | 82 | 0.480 |
Why?
|
| Fucosyltransferases | 6 | 2021 | 29 | 0.470 |
Why?
|
| Microscopy, Electron | 18 | 2010 | 396 | 0.470 |
Why?
|
| Cloning, Molecular | 12 | 2022 | 898 | 0.470 |
Why?
|
| Viral Core Proteins | 6 | 1998 | 22 | 0.470 |
Why?
|
| Science | 1 | 2015 | 33 | 0.470 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2014 | 31 | 0.460 |
Why?
|
| Luciferases | 1 | 2014 | 132 | 0.450 |
Why?
|
| Immunization, Passive | 2 | 2013 | 120 | 0.440 |
Why?
|
| Career Choice | 1 | 2015 | 147 | 0.430 |
Why?
|
| Calcium Signaling | 4 | 2020 | 244 | 0.430 |
Why?
|
| Infant | 28 | 2024 | 12610 | 0.430 |
Why?
|
| Viral Structural Proteins | 6 | 2014 | 48 | 0.420 |
Why?
|
| Recombination, Genetic | 9 | 2006 | 448 | 0.420 |
Why?
|
| Models, Theoretical | 1 | 2015 | 363 | 0.420 |
Why?
|
| Adjuvants, Immunologic | 6 | 2014 | 381 | 0.410 |
Why?
|
| Cricetinae | 6 | 2020 | 422 | 0.410 |
Why?
|
| Base Sequence | 24 | 2014 | 3109 | 0.410 |
Why?
|
| Single-Chain Antibodies | 4 | 2020 | 44 | 0.410 |
Why?
|
| Sequence Homology, Amino Acid | 10 | 2017 | 658 | 0.400 |
Why?
|
| N-Acetylneuraminic Acid | 5 | 2014 | 27 | 0.400 |
Why?
|
| Recombinant Proteins | 19 | 2012 | 1400 | 0.400 |
Why?
|
| Spodoptera | 15 | 2003 | 44 | 0.400 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2012 | 51 | 0.390 |
Why?
|
| DNA, Viral | 16 | 2016 | 478 | 0.380 |
Why?
|
| Vaccines, Synthetic | 9 | 2003 | 316 | 0.380 |
Why?
|
| Viremia | 3 | 2011 | 129 | 0.380 |
Why?
|
| Histocompatibility Antigens | 2 | 2024 | 19 | 0.380 |
Why?
|
| Binding Sites | 14 | 2023 | 1305 | 0.370 |
Why?
|
| Sequence Alignment | 9 | 2014 | 620 | 0.370 |
Why?
|
| Administration, Oral | 13 | 2006 | 683 | 0.370 |
Why?
|
| Bile Ducts | 1 | 2012 | 53 | 0.370 |
Why?
|
| Escherichia coli Proteins | 4 | 2021 | 303 | 0.370 |
Why?
|
| Hepatovirus | 8 | 2001 | 17 | 0.370 |
Why?
|
| Actins | 2 | 2019 | 346 | 0.370 |
Why?
|
| Energy Metabolism | 1 | 2016 | 765 | 0.360 |
Why?
|
| Cholestasis | 1 | 2013 | 155 | 0.360 |
Why?
|
| Osteopontin | 1 | 2011 | 49 | 0.360 |
Why?
|
| Cryptosporidium | 2 | 2022 | 31 | 0.360 |
Why?
|
| Nuclear Export Signals | 1 | 2010 | 2 | 0.350 |
Why?
|
| Up-Regulation | 3 | 2011 | 874 | 0.350 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 171 | 0.350 |
Why?
|
| Dendritic Cells | 2 | 2010 | 414 | 0.350 |
Why?
|
| Picornaviridae | 1 | 2010 | 20 | 0.350 |
Why?
|
| Bacterial Adhesion | 3 | 2020 | 101 | 0.350 |
Why?
|
| Sequence Analysis, DNA | 10 | 2016 | 1762 | 0.350 |
Why?
|
| Porins | 1 | 2010 | 41 | 0.350 |
Why?
|
| Molecular Mimicry | 1 | 2010 | 26 | 0.350 |
Why?
|
| Ostreidae | 9 | 2006 | 27 | 0.350 |
Why?
|
| Cattle | 13 | 2015 | 567 | 0.350 |
Why?
|
| DNA-Directed RNA Polymerases | 5 | 2005 | 121 | 0.340 |
Why?
|
| Golgi Apparatus | 5 | 2012 | 93 | 0.340 |
Why?
|
| Bivalvia | 6 | 2022 | 14 | 0.340 |
Why?
|
| Female | 46 | 2024 | 66704 | 0.330 |
Why?
|
| B-Lymphocytes | 5 | 2017 | 532 | 0.320 |
Why?
|
| Phylogeny | 7 | 2023 | 686 | 0.320 |
Why?
|
| Telomere | 2 | 2021 | 220 | 0.320 |
Why?
|
| Colon | 4 | 2021 | 352 | 0.320 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 682 | 0.310 |
Why?
|
| Fresh Water | 3 | 2025 | 18 | 0.310 |
Why?
|
| Macrophages | 2 | 2010 | 626 | 0.310 |
Why?
|
| Peptide Library | 4 | 2017 | 57 | 0.300 |
Why?
|
| Transcriptome | 4 | 2024 | 978 | 0.300 |
Why?
|
| Liver | 5 | 2021 | 1748 | 0.300 |
Why?
|
| Middle Aged | 16 | 2024 | 26676 | 0.290 |
Why?
|
| Membrane Proteins | 2 | 2013 | 1538 | 0.290 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 372 | 0.290 |
Why?
|
| Viral Tropism | 4 | 2020 | 43 | 0.290 |
Why?
|
| Coculture Techniques | 3 | 2024 | 229 | 0.290 |
Why?
|
| Disease Outbreaks | 13 | 2014 | 320 | 0.290 |
Why?
|
| Water Microbiology | 4 | 2025 | 25 | 0.290 |
Why?
|
| Reference Standards | 5 | 2023 | 235 | 0.290 |
Why?
|
| Catalytic Domain | 5 | 2025 | 162 | 0.290 |
Why?
|
| Hydrogen-Ion Concentration | 8 | 2019 | 443 | 0.290 |
Why?
|
| Tissue Culture Techniques | 3 | 2018 | 67 | 0.290 |
Why?
|
| Antibody Specificity | 2 | 2007 | 204 | 0.280 |
Why?
|
| Young Adult | 8 | 2024 | 9056 | 0.280 |
Why?
|
| Mucin-2 | 2 | 2024 | 41 | 0.280 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2020 | 296 | 0.280 |
Why?
|
| Sapovirus | 3 | 2023 | 6 | 0.270 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2007 | 3 | 0.270 |
Why?
|
| Male | 36 | 2024 | 61443 | 0.270 |
Why?
|
| RNA, Messenger | 9 | 2006 | 2814 | 0.270 |
Why?
|
| Administration, Intranasal | 8 | 2015 | 132 | 0.270 |
Why?
|
| Environmental Monitoring | 3 | 2025 | 65 | 0.270 |
Why?
|
| Host Specificity | 2 | 2020 | 18 | 0.270 |
Why?
|
| Fucose | 2 | 2024 | 21 | 0.260 |
Why?
|
| Animals, Newborn | 5 | 2013 | 1019 | 0.260 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2014 | 1294 | 0.260 |
Why?
|
| Cell Compartmentation | 1 | 2006 | 42 | 0.260 |
Why?
|
| Bacterial Toxins | 3 | 2022 | 176 | 0.250 |
Why?
|
| Immunocompromised Host | 3 | 2021 | 293 | 0.250 |
Why?
|
| Biomedical Research | 2 | 2022 | 516 | 0.250 |
Why?
|
| Infant, Newborn | 18 | 2024 | 8275 | 0.250 |
Why?
|
| Histocytochemistry | 2 | 2016 | 100 | 0.240 |
Why?
|
| Amino Acid Motifs | 3 | 2018 | 200 | 0.240 |
Why?
|
| Swine | 5 | 2022 | 1179 | 0.240 |
Why?
|
| Vaccines | 1 | 2010 | 366 | 0.240 |
Why?
|
| Trisaccharides | 1 | 2025 | 7 | 0.240 |
Why?
|
| Disease Resistance | 1 | 2024 | 23 | 0.230 |
Why?
|
| Diarrhea, Infantile | 4 | 2010 | 35 | 0.230 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2024 | 84 | 0.230 |
Why?
|
| Receptors, Immunologic | 2 | 2020 | 114 | 0.230 |
Why?
|
| Drug Discovery | 2 | 2018 | 171 | 0.230 |
Why?
|
| Cell Polarity | 2 | 2022 | 121 | 0.220 |
Why?
|
| Adhesins, Escherichia coli | 3 | 2020 | 20 | 0.220 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 291 | 0.220 |
Why?
|
| Intracellular Membranes | 3 | 2019 | 63 | 0.220 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2024 | 61 | 0.220 |
Why?
|
| Virus Shedding | 8 | 2014 | 81 | 0.220 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 2527 | 0.220 |
Why?
|
| Disease Models, Animal | 12 | 2014 | 4408 | 0.220 |
Why?
|
| Intestinal Polyposis | 1 | 2023 | 17 | 0.220 |
Why?
|
| Hemorrhagic Disease Virus, Rabbit | 1 | 2023 | 1 | 0.220 |
Why?
|
| Lagovirus | 1 | 2023 | 1 | 0.220 |
Why?
|
| Hares | 1 | 2023 | 1 | 0.220 |
Why?
|
| Adhesins, Bacterial | 2 | 2021 | 75 | 0.210 |
Why?
|
| Hydrogels | 2 | 2021 | 84 | 0.210 |
Why?
|
| Child, Preschool | 16 | 2023 | 14152 | 0.210 |
Why?
|
| Culture Techniques | 1 | 2023 | 86 | 0.210 |
Why?
|
| Genetic Vectors | 2 | 2005 | 940 | 0.210 |
Why?
|
| Clathrin | 1 | 2023 | 24 | 0.210 |
Why?
|
| Hemagglutination | 1 | 2003 | 8 | 0.210 |
Why?
|
| 3' Untranslated Regions | 1 | 2003 | 164 | 0.210 |
Why?
|
| RNA, Double-Stranded | 6 | 2010 | 63 | 0.200 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 157 | 0.200 |
Why?
|
| Reassortant Viruses | 5 | 2015 | 34 | 0.200 |
Why?
|
| Haplorhini | 9 | 2010 | 123 | 0.200 |
Why?
|
| Interleukin-18 | 3 | 2021 | 61 | 0.200 |
Why?
|
| Pyridines | 1 | 2024 | 235 | 0.200 |
Why?
|
| DNA, Complementary | 3 | 2014 | 463 | 0.200 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2022 | 28 | 0.200 |
Why?
|
| Aging | 3 | 1999 | 1181 | 0.200 |
Why?
|
| Enteroendocrine Cells | 2 | 2019 | 21 | 0.200 |
Why?
|
| Cryptosporidium parvum | 1 | 2022 | 27 | 0.200 |
Why?
|
| Cryptosporidiosis | 1 | 2022 | 41 | 0.200 |
Why?
|
| Organ Specificity | 2 | 2018 | 426 | 0.200 |
Why?
|
| Ileum | 2 | 2021 | 134 | 0.200 |
Why?
|
| DNA Mutational Analysis | 3 | 2014 | 810 | 0.190 |
Why?
|
| Child | 15 | 2025 | 24610 | 0.190 |
Why?
|
| Mice, Knockout | 5 | 2024 | 3756 | 0.190 |
Why?
|
| Biguanides | 1 | 2022 | 13 | 0.190 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 140 | 0.190 |
Why?
|
| Spheroids, Cellular | 2 | 2019 | 60 | 0.190 |
Why?
|
| 2-Naphthylamine | 1 | 2021 | 6 | 0.190 |
Why?
|
| Interleukin-8 | 2 | 2019 | 210 | 0.190 |
Why?
|
| Sensitivity and Specificity | 11 | 2019 | 2055 | 0.190 |
Why?
|
| Ricin | 3 | 2006 | 12 | 0.190 |
Why?
|
| Uracil | 1 | 2021 | 14 | 0.190 |
Why?
|
| Stomach | 2 | 2021 | 270 | 0.190 |
Why?
|
| Fimbriae Proteins | 2 | 2021 | 20 | 0.190 |
Why?
|
| Enterohepatic Circulation | 1 | 2021 | 10 | 0.190 |
Why?
|
| Clone Cells | 1 | 2022 | 168 | 0.190 |
Why?
|
| Gene Knockout Techniques | 1 | 2022 | 126 | 0.190 |
Why?
|
| Pyrazoles | 1 | 2024 | 306 | 0.190 |
Why?
|
| Fimbriae, Bacterial | 2 | 2020 | 40 | 0.190 |
Why?
|
| Wnt Signaling Pathway | 1 | 2023 | 193 | 0.180 |
Why?
|
| Integrins | 1 | 2002 | 97 | 0.180 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2021 | 6 | 0.180 |
Why?
|
| Digestive System | 1 | 2001 | 63 | 0.180 |
Why?
|
| Mutagenesis | 3 | 2012 | 345 | 0.180 |
Why?
|
| Mucins | 2 | 2021 | 75 | 0.180 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 2021 | 5 | 0.180 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2024 | 395 | 0.180 |
Why?
|
| Immunologic Tests | 1 | 2001 | 19 | 0.180 |
Why?
|
| Cell Movement | 3 | 2019 | 854 | 0.180 |
Why?
|
| Adenosine Diphosphate | 1 | 2020 | 55 | 0.180 |
Why?
|
| Glycosphingolipids | 1 | 2020 | 11 | 0.180 |
Why?
|
| Oxygen | 1 | 2024 | 556 | 0.180 |
Why?
|
| In Vitro Techniques | 6 | 2010 | 971 | 0.170 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2020 | 16 | 0.170 |
Why?
|
| Fusobacterium nucleatum | 1 | 2020 | 24 | 0.170 |
Why?
|
| CHO Cells | 3 | 2013 | 169 | 0.170 |
Why?
|
| Histidine | 2 | 2019 | 73 | 0.170 |
Why?
|
| Blotting, Western | 7 | 2016 | 1111 | 0.170 |
Why?
|
| Cryoelectron Microscopy | 7 | 2020 | 213 | 0.170 |
Why?
|
| Severe Combined Immunodeficiency | 2 | 2010 | 106 | 0.170 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2021 | 107 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 129 | 0.170 |
Why?
|
| Transfection | 6 | 2015 | 1077 | 0.170 |
Why?
|
| Gluconeogenesis | 1 | 2020 | 106 | 0.170 |
Why?
|
| DNA Primers | 6 | 2010 | 657 | 0.170 |
Why?
|
| Glycochenodeoxycholic Acid | 1 | 2020 | 8 | 0.170 |
Why?
|
| Calnexin | 1 | 2019 | 13 | 0.170 |
Why?
|
| Biopsy | 3 | 2021 | 1242 | 0.170 |
Why?
|
| Molecular Conformation | 5 | 2025 | 106 | 0.170 |
Why?
|
| Ion Transport | 3 | 2015 | 52 | 0.170 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 37 | 0.170 |
Why?
|
| Ligands | 3 | 2018 | 538 | 0.160 |
Why?
|
| Gene Editing | 1 | 2022 | 186 | 0.160 |
Why?
|
| Transcription, Genetic | 10 | 2001 | 1708 | 0.160 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2020 | 39 | 0.160 |
Why?
|
| Pseudopodia | 1 | 2019 | 7 | 0.160 |
Why?
|
| Primary Prevention | 1 | 2021 | 172 | 0.160 |
Why?
|
| Fishes | 1 | 2019 | 38 | 0.160 |
Why?
|
| Sulfonamides | 1 | 2021 | 270 | 0.160 |
Why?
|
| Iodides | 1 | 1999 | 15 | 0.160 |
Why?
|
| Phenotype | 6 | 2024 | 4270 | 0.160 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 134 | 0.160 |
Why?
|
| Cholera Toxin | 4 | 2005 | 49 | 0.160 |
Why?
|
| Birds | 1 | 2019 | 85 | 0.160 |
Why?
|
| Gastrointestinal Hormones | 1 | 2019 | 23 | 0.160 |
Why?
|
| Immunoassay | 4 | 2015 | 131 | 0.160 |
Why?
|
| Casein Kinase Ialpha | 1 | 2018 | 4 | 0.160 |
Why?
|
| Binding, Competitive | 6 | 2006 | 192 | 0.160 |
Why?
|
| Phosphatidic Acids | 1 | 2018 | 1 | 0.150 |
Why?
|
| Microvilli | 3 | 2007 | 71 | 0.150 |
Why?
|
| Phosphotransferases | 1 | 2018 | 41 | 0.150 |
Why?
|
| Proteolipids | 1 | 2018 | 7 | 0.150 |
Why?
|
| Centrifugation, Density Gradient | 4 | 2005 | 97 | 0.150 |
Why?
|
| Virus Inactivation | 1 | 2018 | 9 | 0.150 |
Why?
|
| Bacteriophages | 2 | 2020 | 77 | 0.150 |
Why?
|
| COS Cells | 2 | 2019 | 275 | 0.150 |
Why?
|
| Poverty Areas | 2 | 2009 | 32 | 0.150 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2021 | 207 | 0.150 |
Why?
|
| Mammals | 1 | 2019 | 257 | 0.150 |
Why?
|
| Adolescent | 10 | 2020 | 19414 | 0.150 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 185 | 0.150 |
Why?
|
| Gene Deletion | 4 | 2012 | 793 | 0.150 |
Why?
|
| India | 7 | 2016 | 211 | 0.150 |
Why?
|
| Dimerization | 6 | 2014 | 144 | 0.150 |
Why?
|
| Gene Silencing | 1 | 2018 | 241 | 0.140 |
Why?
|
| Trypsin | 5 | 2001 | 96 | 0.140 |
Why?
|
| Bacterial Translocation | 1 | 2017 | 22 | 0.140 |
Why?
|
| RNA | 4 | 2012 | 576 | 0.140 |
Why?
|
| Macaca mulatta | 3 | 2012 | 489 | 0.140 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 576 | 0.140 |
Why?
|
| Solanum tuberosum | 3 | 2006 | 16 | 0.140 |
Why?
|
| Point Mutation | 4 | 2006 | 351 | 0.140 |
Why?
|
| Caco-2 Cells | 3 | 2018 | 94 | 0.140 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 278 | 0.140 |
Why?
|
| Antibodies | 3 | 2016 | 374 | 0.140 |
Why?
|
| Nucleotidyltransferases | 2 | 2020 | 43 | 0.140 |
Why?
|
| Transplant Recipients | 2 | 2016 | 218 | 0.140 |
Why?
|
| Molecular Weight | 7 | 1999 | 387 | 0.140 |
Why?
|
| Peptides | 3 | 2013 | 812 | 0.140 |
Why?
|
| Sodium | 2 | 2015 | 297 | 0.140 |
Why?
|
| Extraintestinal Pathogenic Escherichia coli | 1 | 2017 | 21 | 0.140 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2021 | 345 | 0.140 |
Why?
|
| Cattle Diseases | 2 | 2015 | 21 | 0.140 |
Why?
|
| Clostridium Infections | 1 | 2020 | 244 | 0.140 |
Why?
|
| Dogs | 4 | 2022 | 772 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 303 | 0.140 |
Why?
|
| Patient Admission | 1 | 2018 | 185 | 0.130 |
Why?
|
| Biological Assay | 2 | 2015 | 104 | 0.130 |
Why?
|
| Nucleotide Motifs | 1 | 2016 | 43 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 561 | 0.130 |
Why?
|
| Saliva | 3 | 2015 | 114 | 0.130 |
Why?
|
| Poliovirus Vaccines | 1 | 2016 | 14 | 0.130 |
Why?
|
| Immunity | 1 | 1998 | 192 | 0.130 |
Why?
|
| Intestine, Large | 1 | 2016 | 14 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 314 | 0.130 |
Why?
|
| Vaccines, DNA | 1 | 1997 | 48 | 0.130 |
Why?
|
| Hemocyanins | 2 | 2010 | 27 | 0.130 |
Why?
|
| Cystic Fibrosis | 1 | 1999 | 259 | 0.130 |
Why?
|
| Peptide Fragments | 5 | 2011 | 781 | 0.130 |
Why?
|
| Arginine | 1 | 2019 | 335 | 0.130 |
Why?
|
| Nanoparticles | 2 | 2018 | 230 | 0.130 |
Why?
|
| RNA Probes | 4 | 1991 | 30 | 0.130 |
Why?
|
| Milk | 1 | 2017 | 119 | 0.130 |
Why?
|
| Developing Countries | 1 | 2018 | 271 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 664 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 7 | 2003 | 309 | 0.130 |
Why?
|
| Glucose | 1 | 2020 | 876 | 0.130 |
Why?
|
| Ovalbumin | 2 | 2010 | 319 | 0.130 |
Why?
|
| Inflammation | 2 | 2020 | 1447 | 0.130 |
Why?
|
| Cricetulus | 2 | 2013 | 101 | 0.130 |
Why?
|
| Binding Sites, Antibody | 4 | 2020 | 99 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 1339 | 0.130 |
Why?
|
| Bacteria | 1 | 2019 | 477 | 0.130 |
Why?
|
| Antigens, Differentiation | 1 | 2015 | 62 | 0.120 |
Why?
|
| Gastritis | 1 | 2019 | 372 | 0.120 |
Why?
|
| Global Health | 2 | 2012 | 570 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 887 | 0.120 |
Why?
|
| Cell Line, Tumor | 4 | 2023 | 3422 | 0.120 |
Why?
|
| Proteolysis | 2 | 2019 | 172 | 0.120 |
Why?
|
| Hemagglutination Tests | 2 | 2013 | 11 | 0.120 |
Why?
|
| Injections, Intramuscular | 4 | 2017 | 194 | 0.120 |
Why?
|
| Virulence | 4 | 2017 | 265 | 0.120 |
Why?
|
| Surface Plasmon Resonance | 3 | 2014 | 47 | 0.120 |
Why?
|
| Food Microbiology | 3 | 2000 | 24 | 0.120 |
Why?
|
| Interferon-alpha | 2 | 2022 | 241 | 0.120 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2014 | 8 | 0.120 |
Why?
|
| Environmental Microbiology | 1 | 1995 | 16 | 0.120 |
Why?
|
| Flagellin | 1 | 2014 | 19 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 4417 | 0.120 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2014 | 9 | 0.120 |
Why?
|
| Biophysical Phenomena | 1 | 2014 | 39 | 0.120 |
Why?
|
| Protein Domains | 3 | 2021 | 236 | 0.120 |
Why?
|
| Copepoda | 1 | 2014 | 6 | 0.110 |
Why?
|
| Enzyme Precursors | 1 | 2014 | 25 | 0.110 |
Why?
|
| Membrane Transport Proteins | 1 | 2015 | 174 | 0.110 |
Why?
|
| Glycomics | 3 | 2024 | 15 | 0.110 |
Why?
|
| Ion Channels | 1 | 2015 | 191 | 0.110 |
Why?
|
| Rats, Inbred Lew | 2 | 2006 | 68 | 0.110 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2014 | 50 | 0.110 |
Why?
|
| Kinetics | 10 | 2015 | 1330 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 86 | 0.110 |
Why?
|
| Helicobacter pylori | 2 | 2019 | 1324 | 0.110 |
Why?
|
| Temperature | 3 | 2021 | 307 | 0.110 |
Why?
|
| Helicobacter Infections | 2 | 2019 | 1267 | 0.110 |
Why?
|
| Stromal Interaction Molecule 1 | 1 | 2013 | 7 | 0.110 |
Why?
|
| Immunoglobulin Fab Fragments | 4 | 2021 | 62 | 0.110 |
Why?
|
| Rats | 4 | 2006 | 3728 | 0.110 |
Why?
|
| Viral Fusion Proteins | 3 | 2015 | 76 | 0.110 |
Why?
|
| Rodent Diseases | 2 | 2011 | 17 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2006 | 387 | 0.110 |
Why?
|
| Disease Susceptibility | 4 | 2004 | 300 | 0.100 |
Why?
|
| Acute Disease | 2 | 2014 | 1095 | 0.100 |
Why?
|
| Longitudinal Studies | 4 | 2012 | 1319 | 0.100 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2012 | 12 | 0.100 |
Why?
|
| Nucleic Acid Hybridization | 6 | 1991 | 394 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1130 | 0.100 |
Why?
|
| Travel | 1 | 2014 | 115 | 0.100 |
Why?
|
| Hybridomas | 3 | 2016 | 42 | 0.100 |
Why?
|
| Autophagy-Related Proteins | 1 | 2012 | 35 | 0.100 |
Why?
|
| Nucleoside-Triphosphatase | 1 | 2012 | 3 | 0.100 |
Why?
|
| Disease Transmission, Infectious | 3 | 2004 | 84 | 0.100 |
Why?
|
| Organ Transplantation | 1 | 2015 | 168 | 0.100 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2012 | 38 | 0.100 |
Why?
|
| Unfolded Protein Response | 1 | 2012 | 62 | 0.100 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 2003 | 108 | 0.100 |
Why?
|
| Human Experimentation | 1 | 2012 | 36 | 0.100 |
Why?
|
| Protein Biosynthesis | 5 | 2000 | 666 | 0.100 |
Why?
|
| Hemagglutination, Viral | 1 | 2011 | 10 | 0.100 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1992 | 44 | 0.100 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2013 | 139 | 0.100 |
Why?
|
| Intracellular Space | 1 | 2012 | 49 | 0.100 |
Why?
|
| Type C Phospholipases | 3 | 2003 | 28 | 0.100 |
Why?
|
| Immune Sera | 3 | 2000 | 95 | 0.100 |
Why?
|
| Multienzyme Complexes | 1 | 1992 | 89 | 0.090 |
Why?
|
| DiGeorge Syndrome | 1 | 1992 | 80 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2010 | 2878 | 0.090 |
Why?
|
| GTPase-Activating Proteins | 2 | 2023 | 87 | 0.090 |
Why?
|
| Fluoroimmunoassay | 1 | 2011 | 6 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2012 | 626 | 0.090 |
Why?
|
| Mannosidases | 1 | 2011 | 19 | 0.090 |
Why?
|
| Antigenic Variation | 4 | 2021 | 39 | 0.090 |
Why?
|
| Nanostructures | 1 | 2011 | 49 | 0.090 |
Why?
|
| Vagina | 2 | 2003 | 185 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 442 | 0.090 |
Why?
|
| Solutions | 1 | 2010 | 65 | 0.090 |
Why?
|
| Crystallography | 2 | 2025 | 40 | 0.090 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2010 | 10 | 0.090 |
Why?
|
| Vaccines, Attenuated | 3 | 2003 | 175 | 0.090 |
Why?
|
| Models, Chemical | 1 | 2010 | 86 | 0.090 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2021 | 100 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1992 | 235 | 0.090 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2010 | 51 | 0.090 |
Why?
|
| Receptors, Chemokine | 1 | 2010 | 45 | 0.090 |
Why?
|
| Receptors, IgG | 1 | 2010 | 59 | 0.080 |
Why?
|
| Genetic Variation | 4 | 2019 | 1505 | 0.080 |
Why?
|
| Biofilms | 2 | 2021 | 82 | 0.080 |
Why?
|
| Tetanus Toxoid | 1 | 2010 | 45 | 0.080 |
Why?
|
| Telomerase | 2 | 2021 | 169 | 0.080 |
Why?
|
| GPI-Linked Proteins | 1 | 2010 | 101 | 0.080 |
Why?
|
| Time Factors | 7 | 2011 | 6302 | 0.080 |
Why?
|
| Swine Diseases | 1 | 1990 | 37 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2006 | 586 | 0.080 |
Why?
|
| Hemagglutinins, Viral | 2 | 1994 | 25 | 0.080 |
Why?
|
| Glycosylation | 3 | 2024 | 124 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 3402 | 0.080 |
Why?
|
| Plants, Genetically Modified | 2 | 2006 | 42 | 0.080 |
Why?
|
| Terminology as Topic | 1 | 2011 | 224 | 0.080 |
Why?
|
| Gene Expression | 4 | 2017 | 1554 | 0.080 |
Why?
|
| Blotting, Northern | 2 | 2005 | 263 | 0.080 |
Why?
|
| Mutation | 5 | 2019 | 5906 | 0.080 |
Why?
|
| Age Factors | 7 | 2006 | 2815 | 0.080 |
Why?
|
| Cell Membrane Permeability | 3 | 1999 | 74 | 0.080 |
Why?
|
| Urban Population | 2 | 2009 | 228 | 0.080 |
Why?
|
| Integrin alpha1beta1 | 1 | 2008 | 4 | 0.080 |
Why?
|
| Integrin alpha2beta1 | 1 | 2008 | 8 | 0.080 |
Why?
|
| United States | 6 | 2015 | 10884 | 0.070 |
Why?
|
| Protein Subunits | 2 | 2006 | 165 | 0.070 |
Why?
|
| Immunoglobulins | 2 | 2022 | 173 | 0.070 |
Why?
|
| Biological Transport | 3 | 2016 | 355 | 0.070 |
Why?
|
| Tissue Scaffolds | 2 | 2020 | 80 | 0.070 |
Why?
|
| Hospitalization | 2 | 2006 | 1784 | 0.070 |
Why?
|
| Nucleic Acid Conformation | 3 | 2006 | 186 | 0.070 |
Why?
|
| Substrate Specificity | 3 | 2016 | 295 | 0.070 |
Why?
|
| DEAD Box Protein 58 | 1 | 2007 | 12 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 1992 | 483 | 0.070 |
Why?
|
| Protein Structure, Secondary | 3 | 2008 | 238 | 0.070 |
Why?
|
| Staining and Labeling | 3 | 2014 | 184 | 0.070 |
Why?
|
| Lactase-Phlorizin Hydrolase | 1 | 2007 | 21 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 1989 | 420 | 0.070 |
Why?
|
| Protein Precursors | 2 | 2020 | 150 | 0.070 |
Why?
|
| Aged | 4 | 2019 | 19656 | 0.070 |
Why?
|
| Cell-Free System | 2 | 2000 | 104 | 0.070 |
Why?
|
| Incidence | 2 | 2012 | 3131 | 0.070 |
Why?
|
| Mice, Mutant Strains | 2 | 2020 | 385 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 1097 | 0.070 |
Why?
|
| Conserved Sequence | 2 | 2018 | 290 | 0.070 |
Why?
|
| Respiratory Tract Infections | 1 | 2009 | 274 | 0.070 |
Why?
|
| Geographic Information Systems | 1 | 2006 | 41 | 0.070 |
Why?
|
| Child Day Care Centers | 3 | 1993 | 26 | 0.070 |
Why?
|
| Antigens, Bacterial | 2 | 2005 | 314 | 0.070 |
Why?
|
| Cohort Studies | 5 | 2016 | 4821 | 0.070 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2007 | 131 | 0.070 |
Why?
|
| Vesicular exanthema of swine virus | 1 | 2006 | 1 | 0.070 |
Why?
|
| Hydrogen Bonding | 2 | 2012 | 80 | 0.070 |
Why?
|
| Neoplasms | 1 | 2021 | 2794 | 0.070 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2006 | 9 | 0.070 |
Why?
|
| Homeostasis | 1 | 2010 | 704 | 0.060 |
Why?
|
| X-Rays | 1 | 2006 | 27 | 0.060 |
Why?
|
| Cats | 2 | 2023 | 118 | 0.060 |
Why?
|
| Serotyping | 4 | 2002 | 178 | 0.060 |
Why?
|
| Biomarkers | 1 | 2015 | 3105 | 0.060 |
Why?
|
| Shiga Toxin 2 | 1 | 2005 | 1 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 1 | 2006 | 75 | 0.060 |
Why?
|
| Double-Blind Method | 3 | 2015 | 1605 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 3 | 1996 | 257 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 1998 | 1078 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2006 | 114 | 0.060 |
Why?
|
| Membranes, Artificial | 2 | 2004 | 27 | 0.060 |
Why?
|
| Drug Design | 1 | 2006 | 153 | 0.060 |
Why?
|
| Antigen-Antibody Complex | 2 | 1999 | 66 | 0.060 |
Why?
|
| Mesocricetus | 1 | 2005 | 72 | 0.060 |
Why?
|
| Lymphocyte Activation | 2 | 2005 | 700 | 0.060 |
Why?
|
| Vaccinia virus | 1 | 2005 | 52 | 0.060 |
Why?
|
| Protein Folding | 2 | 2011 | 216 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 2 | 2016 | 122 | 0.060 |
Why?
|
| Thyrotropin | 1 | 2005 | 56 | 0.060 |
Why?
|
| Paneth Cells | 1 | 2024 | 23 | 0.060 |
Why?
|
| Protein Structure, Quaternary | 3 | 2011 | 98 | 0.060 |
Why?
|
| Kidney | 4 | 2017 | 1360 | 0.060 |
Why?
|
| Oligopeptides | 2 | 2016 | 116 | 0.060 |
Why?
|
| Interleukin-7 | 1 | 2005 | 45 | 0.060 |
Why?
|
| Bacteroides thetaiotaomicron | 1 | 2024 | 8 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 319 | 0.060 |
Why?
|
| Th1 Cells | 1 | 2005 | 153 | 0.060 |
Why?
|
| Bacteria, Anaerobic | 1 | 2024 | 9 | 0.060 |
Why?
|
| Membranes | 1 | 2004 | 23 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2019 | 508 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 859 | 0.060 |
Why?
|
| Hot Temperature | 2 | 2022 | 136 | 0.060 |
Why?
|
| Glycopeptides | 1 | 2024 | 28 | 0.060 |
Why?
|
| Enterovirus Infections | 1 | 2005 | 49 | 0.060 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2004 | 29 | 0.060 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2023 | 5 | 0.050 |
Why?
|
| Placebos | 2 | 2015 | 237 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 199 | 0.050 |
Why?
|
| Goblet Cells | 1 | 2024 | 103 | 0.050 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2003 | 20 | 0.050 |
Why?
|
| Risk Factors | 3 | 2015 | 10278 | 0.050 |
Why?
|
| Fura-2 | 1 | 2003 | 12 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 25 | 0.050 |
Why?
|
| Crystallization | 3 | 2012 | 83 | 0.050 |
Why?
|
| Sequence Deletion | 2 | 1997 | 528 | 0.050 |
Why?
|
| Solubility | 2 | 2011 | 139 | 0.050 |
Why?
|
| Spectrum Analysis | 1 | 2003 | 65 | 0.050 |
Why?
|
| Laboratories | 1 | 2004 | 81 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 1243 | 0.050 |
Why?
|
| Pan troglodytes | 1 | 2003 | 70 | 0.050 |
Why?
|
| Insecta | 3 | 1992 | 58 | 0.050 |
Why?
|
| Seawater | 1 | 2022 | 12 | 0.050 |
Why?
|
| Stem Cell Niche | 1 | 2023 | 57 | 0.050 |
Why?
|
| Osmolar Concentration | 3 | 2010 | 176 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2003 | 205 | 0.050 |
Why?
|
| Serotonin | 1 | 2023 | 212 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 1994 | 581 | 0.050 |
Why?
|
| Galectins | 1 | 2022 | 22 | 0.050 |
Why?
|
| Ribavirin | 1 | 2022 | 85 | 0.050 |
Why?
|
| Receptors, Collagen | 1 | 2002 | 7 | 0.050 |
Why?
|
| Serologic Tests | 2 | 2014 | 118 | 0.050 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2002 | 20 | 0.050 |
Why?
|
| Integrin alpha2 | 1 | 2002 | 9 | 0.050 |
Why?
|
| Sialic Acids | 1 | 2002 | 20 | 0.050 |
Why?
|
| Vacuoles | 1 | 2002 | 25 | 0.050 |
Why?
|
| GTP-Binding Proteins | 2 | 1992 | 179 | 0.050 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2002 | 51 | 0.050 |
Why?
|
| Integrin beta1 | 1 | 2002 | 56 | 0.050 |
Why?
|
| Integrin alpha4beta1 | 1 | 2002 | 37 | 0.050 |
Why?
|
| Glycoconjugates | 1 | 2021 | 7 | 0.050 |
Why?
|
| Polyproteins | 1 | 2021 | 8 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 820 | 0.050 |
Why?
|
| Neuraminidase | 1 | 2002 | 36 | 0.050 |
Why?
|
| Endosomes | 1 | 2022 | 64 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 51 | 0.050 |
Why?
|
| Lung | 2 | 2021 | 1492 | 0.050 |
Why?
|
| DNA | 5 | 2006 | 1621 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 1994 | 1017 | 0.050 |
Why?
|
| Laminin | 1 | 2021 | 69 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2021 | 88 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 668 | 0.050 |
Why?
|
| Calcitriol | 1 | 2021 | 80 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2016 | 5169 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2022 | 149 | 0.050 |
Why?
|
| Transcytosis | 1 | 2021 | 2 | 0.050 |
Why?
|
| Surface Properties | 2 | 2011 | 81 | 0.050 |
Why?
|
| Type III Secretion Systems | 1 | 2021 | 2 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2003 | 505 | 0.040 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2021 | 10 | 0.040 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2020 | 5 | 0.040 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2020 | 8 | 0.040 |
Why?
|
| Models, Structural | 2 | 1997 | 51 | 0.040 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Cell Surface Display Techniques | 1 | 2020 | 10 | 0.040 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2020 | 10 | 0.040 |
Why?
|
| Genomic Library | 1 | 2020 | 42 | 0.040 |
Why?
|
| Flagella | 1 | 2020 | 28 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2020 | 44 | 0.040 |
Why?
|
| Palivizumab | 1 | 2021 | 47 | 0.040 |
Why?
|
| Epithelium | 1 | 2002 | 365 | 0.040 |
Why?
|
| Liposomes | 2 | 2004 | 188 | 0.040 |
Why?
|
| Immunomagnetic Separation | 1 | 2000 | 13 | 0.040 |
Why?
|
| X-Ray Diffraction | 2 | 2014 | 96 | 0.040 |
Why?
|
| Bioreactors | 1 | 2020 | 38 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 45 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2021 | 262 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2021 | 79 | 0.040 |
Why?
|
| Pregnancy | 1 | 2013 | 7221 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2020 | 43 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 1996 | 1095 | 0.040 |
Why?
|
| Reticulocytes | 1 | 2000 | 43 | 0.040 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2020 | 46 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2020 | 69 | 0.040 |
Why?
|
| Proteomics | 1 | 2024 | 506 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2000 | 106 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 587 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 239 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 117 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 317 | 0.040 |
Why?
|
| Sporozoites | 1 | 2020 | 2 | 0.040 |
Why?
|
| Oocysts | 1 | 2020 | 3 | 0.040 |
Why?
|
| Restaurants | 1 | 2000 | 15 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2020 | 119 | 0.040 |
Why?
|
| RNA Viruses | 1 | 2000 | 36 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 2020 | 190 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2002 | 430 | 0.040 |
Why?
|
| Meat | 1 | 2000 | 48 | 0.040 |
Why?
|
| Perfusion | 1 | 2021 | 206 | 0.040 |
Why?
|
| Moths | 3 | 1994 | 22 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2020 | 151 | 0.040 |
Why?
|
| Antibodies, Heterophile | 1 | 1999 | 10 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2020 | 77 | 0.040 |
Why?
|
| Prevalence | 3 | 2016 | 2458 | 0.040 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 1999 | 44 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 239 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 117 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 1720 | 0.040 |
Why?
|
| Picornaviridae Infections | 2 | 1990 | 48 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2019 | 39 | 0.040 |
Why?
|
| RANK Ligand | 1 | 2019 | 52 | 0.040 |
Why?
|
| Injections | 1 | 1999 | 155 | 0.040 |
Why?
|
| Guanosine Triphosphate | 3 | 1996 | 51 | 0.040 |
Why?
|
| Seasons | 3 | 2006 | 312 | 0.040 |
Why?
|
| China | 1 | 2019 | 246 | 0.040 |
Why?
|
| Hemagglutination Inhibition Tests | 2 | 2011 | 113 | 0.040 |
Why?
|
| Bariatric Surgery | 1 | 2020 | 121 | 0.040 |
Why?
|
| Microtubules | 1 | 2019 | 189 | 0.040 |
Why?
|
| Chlorine | 1 | 2018 | 15 | 0.040 |
Why?
|
| Precipitin Tests | 2 | 1996 | 156 | 0.040 |
Why?
|
| Alcohols | 1 | 2018 | 18 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 1704 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2021 | 280 | 0.040 |
Why?
|
| Exocytosis | 1 | 2018 | 63 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2020 | 808 | 0.040 |
Why?
|
| Cross Infection | 2 | 1992 | 313 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 738 | 0.040 |
Why?
|
| Membrane Microdomains | 1 | 2018 | 62 | 0.040 |
Why?
|
| Endocytosis | 1 | 2018 | 125 | 0.040 |
Why?
|
| Reference Values | 1 | 1999 | 719 | 0.040 |
Why?
|
| Macromolecular Substances | 4 | 2006 | 184 | 0.040 |
Why?
|
| Body Weight | 1 | 2002 | 989 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 3175 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 103 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1997 | 13 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2001 | 259 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1757 | 0.030 |
Why?
|
| Cytosol | 2 | 1995 | 162 | 0.030 |
Why?
|
| RNA-Directed DNA Polymerase | 2 | 1997 | 46 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2018 | 284 | 0.030 |
Why?
|
| Spleen | 1 | 2017 | 281 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 682 | 0.030 |
Why?
|
| Carbachol | 1 | 1996 | 18 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2016 | 34 | 0.030 |
Why?
|
| Antigens | 1 | 2016 | 156 | 0.030 |
Why?
|
| Colforsin | 1 | 1996 | 51 | 0.030 |
Why?
|
| Cryopreservation | 1 | 1996 | 73 | 0.030 |
Why?
|
| Intestinal Secretions | 1 | 2015 | 4 | 0.030 |
Why?
|
| Transformation, Genetic | 2 | 2006 | 35 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 2015 | 22 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2015 | 8 | 0.030 |
Why?
|
| Chlorides | 1 | 1996 | 107 | 0.030 |
Why?
|
| Texas | 3 | 2015 | 3571 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 38 | 0.030 |
Why?
|
| Microscopy | 1 | 2016 | 117 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 356 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2023 | 2377 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 2006 | 95 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1996 | 291 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1995 | 58 | 0.030 |
Why?
|
| Virosomes | 1 | 2014 | 4 | 0.030 |
Why?
|
| Sewage | 1 | 1995 | 8 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 352 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2014 | 39 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 290 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 2014 | 18 | 0.030 |
Why?
|
| Lipid A | 1 | 2014 | 23 | 0.030 |
Why?
|
| Interferometry | 1 | 2014 | 26 | 0.030 |
Why?
|
| Erythrocytes | 2 | 2012 | 221 | 0.030 |
Why?
|
| Calorimetry | 1 | 2014 | 62 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 352 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2020 | 833 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2014 | 101 | 0.030 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2013 | 15 | 0.030 |
Why?
|
| Sex Factors | 2 | 2009 | 1275 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 155 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 2 | 1990 | 122 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 193 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 325 | 0.030 |
Why?
|
| Estrenes | 2 | 2008 | 21 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2015 | 6123 | 0.030 |
Why?
|
| Pyrrolidinones | 2 | 2008 | 17 | 0.030 |
Why?
|
| Mexico | 1 | 2014 | 181 | 0.030 |
Why?
|
| Poly A | 1 | 1993 | 59 | 0.030 |
Why?
|
| Cell Aggregation | 1 | 2013 | 24 | 0.030 |
Why?
|
| Zoonoses | 1 | 2013 | 44 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2009 | 12272 | 0.030 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1992 | 29 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1995 | 360 | 0.030 |
Why?
|
| DNA, Recombinant | 1 | 1992 | 105 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 135 | 0.030 |
Why?
|
| Immunoblotting | 2 | 1992 | 312 | 0.030 |
Why?
|
| Graft Survival | 1 | 2015 | 532 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2005 | 3310 | 0.020 |
Why?
|
| Viral Load | 1 | 2014 | 389 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2012 | 161 | 0.020 |
Why?
|
| Adenoviruses, Human | 1 | 1992 | 81 | 0.020 |
Why?
|
| Adenovirus Infections, Human | 1 | 1992 | 50 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2016 | 1187 | 0.020 |
Why?
|
| Hardness | 1 | 2011 | 5 | 0.020 |
Why?
|
| Compressive Strength | 1 | 2011 | 12 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 1992 | 99 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 461 | 0.020 |
Why?
|
| Materials Testing | 1 | 2011 | 72 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 556 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1992 | 369 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2015 | 588 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 60 | 0.020 |
Why?
|
| Static Electricity | 1 | 2011 | 45 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 297 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 168 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 190 | 0.020 |
Why?
|
| Codon | 1 | 1991 | 98 | 0.020 |
Why?
|
| Adsorption | 1 | 2010 | 32 | 0.020 |
Why?
|
| Hospitals, Voluntary | 1 | 1990 | 4 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1273 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2010 | 93 | 0.020 |
Why?
|
| Hepatitis A | 2 | 2001 | 32 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 13 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1990 | 236 | 0.020 |
Why?
|
| Mothers | 1 | 2013 | 356 | 0.020 |
Why?
|
| Insect Viruses | 1 | 1989 | 9 | 0.020 |
Why?
|
| Particle Size | 1 | 2010 | 124 | 0.020 |
Why?
|
| Dehydration | 1 | 2010 | 39 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1990 | 163 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 1992 | 245 | 0.020 |
Why?
|
| Microsomes | 1 | 1989 | 55 | 0.020 |
Why?
|
| Chemokines | 1 | 2010 | 134 | 0.020 |
Why?
|
| Biotin | 1 | 1989 | 45 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 1989 | 167 | 0.020 |
Why?
|
| Failure to Thrive | 1 | 2010 | 90 | 0.020 |
Why?
|
| Primates | 1 | 1989 | 77 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 650 | 0.020 |
Why?
|
| Freund's Adjuvant | 2 | 1999 | 27 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2371 | 0.020 |
Why?
|
| Immunoglobulin M | 2 | 2005 | 212 | 0.020 |
Why?
|
| Parainfluenza Virus 1, Human | 1 | 1988 | 4 | 0.020 |
Why?
|
| Morbidity | 1 | 2009 | 248 | 0.020 |
Why?
|
| Hexosaminidases | 1 | 1988 | 7 | 0.020 |
Why?
|
| Androstadienes | 1 | 2008 | 50 | 0.020 |
Why?
|
| Tryptophan | 1 | 2008 | 91 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2011 | 1086 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 235 | 0.020 |
Why?
|
| Phosphotungstic Acid | 1 | 1987 | 1 | 0.020 |
Why?
|
| Molybdenum | 1 | 1987 | 15 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 802 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 1390 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1987 | 88 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2008 | 347 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2008 | 240 | 0.020 |
Why?
|
| Morphogenesis | 1 | 1988 | 212 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 1987 | 111 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 1987 | 199 | 0.020 |
Why?
|
| Vaccines, Edible | 1 | 2006 | 1 | 0.020 |
Why?
|
| Fetus | 1 | 2010 | 586 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 858 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2006 | 40 | 0.020 |
Why?
|
| Agrobacterium tumefaciens | 1 | 2006 | 4 | 0.020 |
Why?
|
| Sulfones | 1 | 2006 | 74 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2006 | 65 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2006 | 256 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 2005 | 105 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2005 | 42 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 1990 | 768 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 4683 | 0.020 |
Why?
|
| Biotechnology | 1 | 2005 | 56 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 210 | 0.010 |
Why?
|
| Receptors, Thyrotropin | 1 | 2005 | 10 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 2005 | 57 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 2005 | 41 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2005 | 16339 | 0.010 |
Why?
|
| Animals, Outbred Strains | 1 | 2004 | 12 | 0.010 |
Why?
|
| Breast Feeding | 1 | 2006 | 221 | 0.010 |
Why?
|
| Vesivirus | 1 | 2004 | 1 | 0.010 |
Why?
|
| Peyer's Patches | 1 | 2004 | 21 | 0.010 |
Why?
|
| Freezing | 2 | 1997 | 28 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 2004 | 86 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 605 | 0.010 |
Why?
|
| Cytokines | 1 | 2010 | 1293 | 0.010 |
Why?
|
| Phosphatidylserines | 1 | 2004 | 46 | 0.010 |
Why?
|
| Community-Acquired Infections | 1 | 2006 | 241 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2006 | 390 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 358 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1993 | 933 | 0.010 |
Why?
|
| Permeability | 1 | 2004 | 124 | 0.010 |
Why?
|
| Software | 1 | 1988 | 687 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2005 | 390 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2004 | 2182 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1993 | 1316 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2002 | 61 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2002 | 109 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2001 | 91 | 0.010 |
Why?
|
| Computational Biology | 1 | 2005 | 819 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 462 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1989 | 48 | 0.010 |
Why?
|
| Hemolymph | 1 | 1998 | 3 | 0.010 |
Why?
|
| Saponins | 1 | 1998 | 22 | 0.010 |
Why?
|
| Aluminum Compounds | 1 | 1998 | 17 | 0.010 |
Why?
|
| Phosphates | 1 | 1998 | 115 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1998 | 391 | 0.010 |
Why?
|
| Nasal Mucosa | 1 | 1998 | 66 | 0.010 |
Why?
|
| DNA Probes | 1 | 1996 | 124 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 1996 | 155 | 0.010 |
Why?
|
| Consumer Product Safety | 1 | 1996 | 32 | 0.010 |
Why?
|
| Ionomycin | 1 | 1995 | 19 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1995 | 22 | 0.010 |
Why?
|
| Barium | 1 | 1995 | 17 | 0.010 |
Why?
|
| Terpenes | 1 | 1995 | 28 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1995 | 55 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 161 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1994 | 54 | 0.010 |
Why?
|
| Desiccation | 1 | 1994 | 44 | 0.010 |
Why?
|
| Hydroxyapatites | 1 | 1992 | 3 | 0.010 |
Why?
|
| Myristic Acid | 1 | 1992 | 6 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1992 | 14 | 0.010 |
Why?
|
| Myristic Acids | 1 | 1992 | 7 | 0.010 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 1992 | 13 | 0.010 |
Why?
|
| Chromatography | 1 | 1992 | 44 | 0.010 |
Why?
|
| Durapatite | 1 | 1992 | 17 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1992 | 23 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1992 | 66 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1992 | 28 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1992 | 34 | 0.010 |
Why?
|
| Rod Cell Outer Segment | 1 | 1992 | 48 | 0.010 |
Why?
|
| Adenylyl Cyclases | 1 | 1992 | 83 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1992 | 104 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1992 | 126 | 0.010 |
Why?
|
| Viral Plaque Assay | 1 | 1991 | 42 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1990 | 273 | 0.010 |
Why?
|
| Vomiting | 1 | 1990 | 103 | 0.000 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 1992 | 316 | 0.000 |
Why?
|
| Immunosorbent Techniques | 1 | 1989 | 26 | 0.000 |
Why?
|
| Arizona | 1 | 1989 | 23 | 0.000 |
Why?
|
| Placenta | 1 | 1992 | 508 | 0.000 |
Why?
|
| Monensin | 1 | 1987 | 10 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1987 | 144 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1987 | 680 | 0.000 |
Why?
|
| Brain | 1 | 1992 | 3014 | 0.000 |
Why?
|
| Surveys and Questionnaires | 1 | 1989 | 3675 | 0.000 |
Why?
|